BCL2 and cholangiocarcinoma: These studies highlight the potential of TC extract as a therapeutic agent for enhancing apoptosis in CCA cells, possibly through the induction of the Bax/Bcl-2 ratio by bioactive compounds such as spirostanol saponins and diarylheptanoids.